Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer

  • Technology appraisal guidance
  • TA946
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence